Wilzin (zinc)
- Region
- 🇪🇺 EU
- Active substance
- zinc
- Company
- Recordati Rare Diseases
- Status
- Authorised
- Therapeutic area
- Hepatolenticular Degeneration
- EU approval
- Tue 12 Oct 2004
- Application
- EMEA/H/C/000535
- ATC
- A16AX05
- Official record
- www.ema.europa.eu
Indication
Treatment of Wilson's disease.
Regulatory milestones
No milestones recorded in the last year.
Follow Wilzin
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.